Who invested in VenatoRx Pharmaceuticals?
VenatoRx Pharmaceuticals's investors include Versant Ventures and Foresite Capital.
United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$28Mraised across 2 rounds since 2013, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $13M sold, first sale Aug 2022
No investor was named in the report.
Reported by sec.govSEC filing: $3.4M sold, first sale Nov 2013
From the SEC filings it signed: 3 on the team.
On the board, as filediMartin J HeideckerSergei J PetukhovTimothy J HainesTomas C Heyman
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
VenatoRx Pharmaceuticals's investors include Versant Ventures and Foresite Capital.
VenatoRx Pharmaceuticals has raised $28M across 2 rounds since 2013.
VenatoRx Pharmaceuticals's most recent round was a Venture of $25M in Sept 2022.
Its most recent round, $25M in Sept 2022, is also its largest on record.
VenatoRx Pharmaceuticals's first round on record, in Sept 2022, was backed by Versant Ventures and Foresite Capital.
VenatoRx Pharmaceuticals's latest named round is a Venture, in Sept 2022.
VenatoRx Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.